FDA Urges Guillain-Barré Syndrome Warning On Labels Of RSV Vaccines Abrysvo And Arexvy
The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...
Verywell Health on MSN7h
The 'Quad-Demic' Is Creeping Up This Winter. Here's How To Protect Yourself
The best way to protect yourself from the flu and COVID is to get vaccinated. This can reduce your chances of getting sick ...
Becker's Hospital Review10h
FDA mandates warnings for 2 RSV vaccines
The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...
Managed Healthcare Executive5h
FDA Requires Guillain-Barré Warning for Abrysvo and Arexvy
Regulators say, however, the benefits of vaccination with Abrysvo and Arexvy in preventing respiratory syncytial virus ...
Greeley Tribune on MSN23h
Banner Health: RSV vaccine significantly lowers risk of newborns contracting respiratory illness
Banner Health encourages pregnant women to reduce their newborn’s risk of developing a severe illness through vaccination. Respiratory syncytial virus (RSV) season typically peaks in the winter and ...
kffhealthnews12h
USDA Says 15 More States Have Signed Up For National Milk Testing Program
The program, which began Dec. 6 in the wake of ongoing H5N1 outbreaks at dairy farms, now includes 28 states covering 65% of the country's milk production. Other public health news is on chronic ...
Managed Healthcare Executive4h
RSV Vaccine Highly Effective in Preventing Severe Illness in Older Adults
U.S. approved the RSVpreF vaccine for adults 60 years and older in 2023, recommending it only based on individual’s decisions ...